Latest filing published 13 Jan 2026 for LISATA THERAPEUTICS, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gregory B. Brown, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Lisata Therapeutics, Inc. and Cambrex Corp. The record holds 19 filings, for trades running from 10 October 2016 to 9 January 2026.
Every open-market trade on record is a sale: 1 sale worth €488k. Outside the open market, there are 15 share grants and 3 option exercises.
The newest entry dates from 13 January 2026: a share grant, in Lisata Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations